FR2573427B1 - Derives de flavolignanes, procedes pour leur preparation et medicaments contenant ces composes - Google Patents

Derives de flavolignanes, procedes pour leur preparation et medicaments contenant ces composes

Info

Publication number
FR2573427B1
FR2573427B1 FR858517321A FR8517321A FR2573427B1 FR 2573427 B1 FR2573427 B1 FR 2573427B1 FR 858517321 A FR858517321 A FR 858517321A FR 8517321 A FR8517321 A FR 8517321A FR 2573427 B1 FR2573427 B1 FR 2573427B1
Authority
FR
France
Prior art keywords
flavolignan
derivatives
compounds
preparation
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR858517321A
Other languages
English (en)
French (fr)
Other versions
FR2573427A1 (fr
Inventor
Reinhard Braatz
Klaus Gorler
Gunter Halbach
Hartwig Soicke
Karlheinz Schmidt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Madaus Holding GmbH
Madaus GmbH
Original Assignee
Dr Madaus GmbH and Co
Madaus GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Madaus GmbH and Co, Madaus GmbH filed Critical Dr Madaus GmbH and Co
Publication of FR2573427A1 publication Critical patent/FR2573427A1/fr
Application granted granted Critical
Publication of FR2573427B1 publication Critical patent/FR2573427B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Silicon Compounds (AREA)
FR858517321A 1984-11-22 1985-11-22 Derives de flavolignanes, procedes pour leur preparation et medicaments contenant ces composes Expired FR2573427B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843442639 DE3442639A1 (de) 1984-11-22 1984-11-22 Flavolignanderivate, verfahren zu deren herstellung und arzneimittel, die diese verbindungen enthalten

Publications (2)

Publication Number Publication Date
FR2573427A1 FR2573427A1 (fr) 1986-05-23
FR2573427B1 true FR2573427B1 (fr) 1989-03-10

Family

ID=6250903

Family Applications (1)

Application Number Title Priority Date Filing Date
FR858517321A Expired FR2573427B1 (fr) 1984-11-22 1985-11-22 Derives de flavolignanes, procedes pour leur preparation et medicaments contenant ces composes

Country Status (29)

Country Link
JP (1) JPS61143377A (hu)
KR (1) KR870001020B1 (hu)
AR (1) AR240931A1 (hu)
AT (1) AT393268B (hu)
BE (1) BE903693A (hu)
CA (1) CA1337124C (hu)
CH (1) CH659473A5 (hu)
CS (1) CS273610B2 (hu)
DD (1) DD259191A1 (hu)
DE (1) DE3442639A1 (hu)
DK (1) DK164865C (hu)
EG (1) EG19424A (hu)
ES (1) ES8609311A1 (hu)
FI (1) FI84064C (hu)
FR (1) FR2573427B1 (hu)
GB (1) GB2167414B (hu)
HU (1) HU195503B (hu)
IE (1) IE58791B1 (hu)
IT (1) IT1190426B (hu)
LU (1) LU86163A1 (hu)
MX (1) MX168415B (hu)
NL (1) NL192387C (hu)
NO (1) NO160205C (hu)
PL (1) PL146890B1 (hu)
PT (1) PT81532B (hu)
SE (1) SE465676B (hu)
SU (1) SU1436875A3 (hu)
YU (1) YU43689B (hu)
ZA (1) ZA858951B (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8716918D0 (en) * 1987-07-17 1987-08-26 Inverni Della Beffa Spa Soluble derivatives of silybin
US5262439A (en) * 1992-04-30 1993-11-16 The Regents Of The University Of California Soluble analogs of probucol
BRPI0608402B8 (pt) * 2005-03-11 2021-05-25 Armaron Bio Pty Ltd compostos de flavonóide e composições compreendendo os mesmos
CN102300570B (zh) * 2007-11-15 2015-01-14 马道斯有限责任公司 用于治疗肝炎的水飞蓟宾组分
RU2482844C2 (ru) * 2007-11-15 2013-05-27 Мадаус Гмбх Силибининовый компонент для лечения гепатита
CA2761656C (en) * 2009-05-14 2017-02-07 Lucio Claudio Rovati Amorphous silibinin for the treatment of viral hepatitis
AU2013286721B2 (en) 2012-07-05 2018-04-26 Nutramax Laboratories, Inc. Compositions comprising a sulforaphane or a sulforaphane precursor and milk thistle extract or powder
CN103113359B (zh) * 2013-02-22 2016-01-06 西安安健药业有限公司 水飞蓟宾二偏琥珀酸酯及其药用盐
CN103193768B (zh) * 2013-02-22 2016-03-30 西安安健药业有限公司 治疗肝病的水飞蓟宾二偏琥珀酸酯异构体
CN103172622B (zh) * 2013-02-22 2015-11-04 西安安健药业有限公司 水飞蓟宾二偏琥珀酸酯的活性异构体

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1963318A1 (de) * 1969-12-17 1971-06-24 Schwabe Willmar Gmbh & Co Silybinhalbester der Bernsteinsaeure und der Phthalsaeure,ihre Salze mit pharmakologisch vertraglichen Basen,Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Arzneipraeparaten

Also Published As

Publication number Publication date
FI854535A (fi) 1986-05-23
PT81532A (de) 1985-12-01
CS273610B2 (en) 1991-03-12
IE58791B1 (en) 1993-11-17
LU86163A1 (de) 1986-03-24
GB2167414B (en) 1989-01-11
GB2167414A (en) 1986-05-29
PL256374A1 (en) 1986-12-02
BE903693A (fr) 1986-05-22
FR2573427A1 (fr) 1986-05-23
AR240931A1 (es) 1991-03-27
DK164865C (da) 1993-01-18
CS837885A2 (en) 1990-08-14
DD259191A1 (de) 1988-08-17
NO160205B (no) 1988-12-12
FI854535A0 (fi) 1985-11-18
NL192387B (nl) 1997-03-03
DK537785A (da) 1986-05-23
FI84064B (fi) 1991-06-28
IE852808L (en) 1986-05-22
HUT40114A (en) 1986-11-28
SU1436875A3 (ru) 1988-11-07
ES549116A0 (es) 1986-09-01
YU178685A (en) 1988-02-29
IT8522932A0 (it) 1985-11-21
CH659473A5 (de) 1987-01-30
IT1190426B (it) 1988-02-16
DE3442639C2 (hu) 1989-08-10
FI84064C (fi) 1991-10-10
ZA858951B (en) 1986-08-27
PL146890B1 (en) 1989-03-31
SE465676B (sv) 1991-10-14
DK164865B (da) 1992-08-31
DE3442639A1 (de) 1986-05-22
GB8528226D0 (en) 1985-12-18
ATA337185A (de) 1991-02-15
EG19424A (en) 1995-02-28
NL192387C (nl) 1997-07-04
SE8505487L (sv) 1986-05-23
YU43689B (en) 1989-10-31
AT393268B (de) 1991-09-25
PT81532B (pt) 1987-11-11
ES8609311A1 (es) 1986-09-01
DK537785D0 (da) 1985-11-21
SE8505487D0 (sv) 1985-11-20
HU195503B (en) 1988-05-30
NO854655L (no) 1986-05-23
MX168415B (es) 1993-05-24
NL8503171A (nl) 1986-06-16
JPS61143377A (ja) 1986-07-01
NO160205C (no) 1989-03-22
AR240931A2 (es) 1991-03-27
KR870001020B1 (ko) 1987-05-23
JPH0432073B2 (hu) 1992-05-28
KR860004056A (ko) 1986-06-16
CA1337124C (en) 1995-09-26

Similar Documents

Publication Publication Date Title
BE896986A (fr) Derives d'indole, procedes pour leur preparation et composition pharmaceutiques les contenant
MC1491A1 (fr) Nouveaux composes bicycliques,procedes pour les preparer et formules pharmaceutiques contenant ces composes
FR2542312B1 (fr) Composes de sulfonium, leur preparation et compositions pharmaceutiques contenant ces composes
MA20292A1 (fr) Nouveaux derives de 2,2' -iminobisethanol, intermediaires pour leur preparation et procedes pour la preparation de ces derives et intermediaires.
MA18829A1 (fr) Derives de la pyrimidine,procedes pour leur preparation,compositions pharmaceutiques contenant ces composes et leur utilisation therapeutique
MA20084A1 (fr) Derives de la furo-(3,4-c)-pyridine leur preparation et compositions therapeutiques contenant ces derives.
BE893378A (fr) Derives de carboximide, procedes pour leur preparation et medicament les contenant
FR2566773B1 (fr) Nouveaux benzamides substitues, procedes de preparation de ces composes et compositions pharmaceutiques les contenant
FR2574793B1 (fr) Composes derives d'indole, compositions pharmaceutiques les contenant et procede pour leur preparation
FR2573427B1 (fr) Derives de flavolignanes, procedes pour leur preparation et medicaments contenant ces composes
BE894927A (fr) Derives de l'ergoline, procede pour leur preparation et medicaments les contenant
MC1454A1 (fr) Composes biaryliques substitues,leur preparation et preparation de medicaments contenant ces composes
BE867638A (fr) Nouvelles 5,11-dihydro-6h-pyrido (2,3-b) (1,4) benzodiazepin-6-ones, procedes pour leur preparation et medicaments renfermant ces composes
BE896418A (fr) Nouveaux derives de carbapenem,compositions pharmaceutiques les contenant composes intermediaires pour leur preparation et leurs procedes de production
MA21588A1 (fr) Derives d'ether de n-pheryl pyrazole-4-yle, compositions les contenant et leur procede de preparation.
BE857138A (fr) Derives peptidiques, procede pour leur preparation et compositions therapeutiques contenant ces composes
BE885507A (fr) Composes heterocycliques, procedes pour leur preparation et compositions pharmaceutiques les contenant
IT1194793B (it) Derivati tiazolidinici ad attivita' farmacologica,procedimento per la loro preparazione e composizioni farmaceutiche contenenti detti derivati
MC1673A1 (fr) Derives aryliques de composes imidazoliques,leur preparation et leur emploi pour la preparation des medicaments
FR2563519B1 (fr) Derives d'iminothiazolidine, procede pour leur preparation et compositions pharmaceutiques les contenant
HUT37423A (en) Process for preparing 1,3-dioxolanyl derivatives and pharmaceutical compositions containing thereof
FR2574429B1 (fr) Acylglycannes extraits de klebsiella, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
FR2496100B1 (fr) Derives de la pyrazoline, leur preparation et medicaments contenant ces substances
FR2603587B1 (fr) Derives de la 2,3,4,5,6,7-hexahydro-2,7-methano-1,5-benzoxazonine (ou -1,4-benzoxazonine), procede pour leur preparation, medicaments les contenant et composes intermediaires
FR2573762B1 (fr) Derives 4-hydroxyphenylthioalkyliques substitues, compositions les contenant et leur procede d'emploi

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse
ST Notification of lapse